A report that seems to partially address this concern from Wu and colleagues revealed that OVOL2 thwarts TGF-β signalling and blocks EMT during breast tumour metastasis by repressing SMAD4 expression and interfering with SMAD4 and SMAD2/3 complex formation (97). The gene discussed is SMAD4; the disease is breast neoplasm.